Asensus Surgical, Inc. will present at LD Micro Main Event XV


Get instant alerts when news breaks on your stocks. Claim your one week free trial for StreetInsider Premium here.


Presentation Tuesday, October 25 at 8:30 a.m. PT

Research Triangle Park, NC–(Newsfile Corp. – October 18, 2022) – Asensus Surgical, Inc. (NYSE American: ASXC), Asensus Surgical, a medical device company that digitizes the interface between surgeon and patient for pioneering a new era of performance-guided surgery,” today announced his presentation at the 15th Annual Main Event on Tuesday, October 25. at 8:30 a.m. PT at the Luxe Sunset Boulevard Hotel. Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present.

Event: LD Micro Main Event XV

Date: Tuesday, October 25, 2022

Time: 8:30 a.m. PT

Register to watch the virtual presentation here.

The LD Micro Main Event XV 2022 will be held at the Luxe Sunset Boulevard Hotel in Los Angeles from October 25-27. This three-day investor conference is expected to feature more than 200 companies, presenting in half-hour increments, as well as private meetings.

About Asensus Surgical, Inc.

Asensus Surgical, Inc. is digitizing the interface between surgeon and patient to usher in a new era of performance-driven surgery by unleashing clinical intelligence for surgeons to achieve consistently superior results and a new standard of surgery. This builds on the foundation of digital laparoscopy with the Senhance surgical system powered by Intelligent Surgical Unit (ISU) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive, and economic gaps that determine surgical outcomes and value-based healthcare. Learn more about performance-guided surgery and digital laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in USA, EU, Japan, Russia and some other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.

Follow Asensus

Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc
Twitter: https://twitter.com/AsensusSurgical
Youtube: https://www.youtube.com/c/transenterix
Vimeo: https://vimeo.com/asxc

About LD Micro

LD Micro aims to be the most crucial resource in the world of micro caps. Whether it’s the index, comprehensive data, or organizing the most important events on an annual basis, LD’s sole mission is to serve as an invaluable asset to anyone wishing to find the next generation large companies.

http://www.ldmicro.com

INVESTOR CONTACT:
Mark Klausner or Mike Vallie, 443-213-0499
[email protected]

MEDIA CONTACT:
Lauren Stredler, 847-271-6891

CG Life
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/140847

Christine E. Phillips